Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.
By M. Coco, Heather Rush. American Journal of Kidney Diseases, 2000
605 citations recorded by the source corpus.
Subfields: Nephrology, Oncology, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/2097d3ff223e531a1534418c98699537afbfb9c8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- G. Block
- Glenn M. Chertow
- M. Norma Ofsthun
- C. Camargo
- Miguel A. Hern'an
- P. Klassen
- Stephen R. Cole
- Peter C. Austin
Citations in the corpus
- Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. (2004, background): “Coco and Rush (33) showed an increased risk of fracture with lower PTH concentrations, although these results were not adjusted for age, gender, race, or other factors jointly associated with PTH and fracture risk.”
- KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) (2009, neutral): “36 (NS); Mean whole (1-84) PTH (pmol/L): 17.”
- Activated injectable vitamin D and hemodialysis survival: a historical cohort study. (2005, background): “Injectable vitamin D therapy is associated with decreased serum levels of PTH, which have been linked to adynamic bone disease (59,60), and increased calcium and phosphorus levels, which have been linked to excess coronary calcification (56,61), important intermediate outcomes that we were unable to”